Issued Patents All Time
Showing 26–50 of 93 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9932402 | Humanized antibodies to iNKT | Alemseged Truneh, Timothy David Jones, James P. Gregson | 2018-04-03 |
| 9879076 | Methods and compositions with immune therapy for treatment of dementia | Sarit Samira, Nurit Rachamim, Michael Tal, Ronald W. Ellis, Idan Rakover +5 more | 2018-01-30 |
| 9714290 | Humanised anti CTLA-4 antibodies | Timothy David Jones, Robert George Edward Holgate | 2017-07-25 |
| 9677055 | Modified forms of Pseudomonas exotoxin A | Timothy David Jones | 2017-06-13 |
| 9605081 | Polynucleotides encoding anti-kit antibodies | Yaron R. Hadari, Elizabeth M Mandel-Bausch, Timothy David Jones, Laura Clare Alexandra Perry | 2017-03-28 |
| 9603911 | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins | Kurt R. Gehlsen, Timothy David Jones, Arron Hearn | 2017-03-28 |
| 9587024 | Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) | David R. Clemmons, Laura A. Maile, Michael Naso, Timothy David Jones, Simon Keen | 2017-03-07 |
| 9447387 | Modified forms of pseudomonas exotoxin A | Timothy David Jones | 2016-09-20 |
| 9371517 | Modified forms of Pseudomonas exotoxin A | Timothy David Jones | 2016-06-21 |
| 9334332 | Anti-kit antibodies | Yaron R. Hadari, Elizabeth M Mandel-Bausch, Timothy David Jones, Laura Clare Alexandra Perry | 2016-05-10 |
| 9321841 | Humanised anti-CD52 antibodies | Timothy David Jones, Robert George Edward Holgate | 2016-04-26 |
| 9325433 | High dynamic range transceiver | Aly M. Ismail, Sai Kwok | 2016-04-26 |
| 9181343 | Antibody specific for CD22 and methods of use thereof | David Rabuka, Robert George Edward Holgate | 2015-11-10 |
| 9102736 | Multispecific deimmunized CD3-binders | Robert Hofmeister, Birgit Kohleisen, Ulla Lenkkeri-Schütz, Christian Itin, Patrick Bauerle +2 more | 2015-08-11 |
| 9102727 | Human anti-PD-1 antibodies and uses therefor | Gordon J. Freeman, Rafi Ahmed, Timothy David Jones, James P. Gregson | 2015-08-11 |
| 9073996 | Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) | David R. Clemmons, Laura A. Maile, Michael Naso, Timothy David Jones, Simon Keen | 2015-07-07 |
| 8975377 | Cancer treatment using humanized antibodies that bind to EphB4 | Parkash Gill, Valery Krasnoperov, Simon Keen, Timothy David Jones | 2015-03-10 |
| 8932586 | Modified forms of Pseudomonas exotoxin A | Timothy David Jones | 2015-01-13 |
| 8758757 | Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) | Josephine M. Cardarelli, Tseng-hui Timothy Chen, David J. King, Christopher R. Bebbington, Sarah L. Pogue +1 more | 2014-06-24 |
| 8716234 | Cytotoxins comprising modified bouganin toxin for the treatment of cancer | Matthew Baker, Koen Hellendoorn, Jeannick Cizeau, Glen MacDonald, Joycelyn Entwistle +2 more | 2014-05-06 |
| 8614298 | Humanized anti-amyloid beta antibodies | Lisa Lynn Shafer, James P. Gregson, Dawn Ann Bembridge, Tim Jones | 2013-12-24 |
| 8552154 | Anti-PD-L1 antibodies and uses therefor | Gordon J. Freeman, Rafi Ahmed, Timothy David Jones, James P. Gregson | 2013-10-08 |
| 8337844 | CD20-binding polypeptide compositions for treating autoimmune disease | Stephen Williams, Stephen D. Gillies | 2012-12-25 |
| 8147832 | CD20-binding polypeptide compositions and methods | Stephen Williams, Stephen D. Gillies | 2012-04-03 |
| 8076459 | Multispecfic deimmunized CD3-binders | Robert Hofmeister, Birgit Kohleisen, Ulla Lenkkeri-Schütz, Christian Itin, Patrick Bauerle +2 more | 2011-12-13 |